Werewolf Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 0.9861 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 47.92M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PREDATOR platform. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatm...